Prostate Cancer - Results from #20

Evaluating the impact of the Radiomics Quality Score: a systematic review and meta-analysis. January 15, 2025

The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages. January 15, 2025

Staging of prostate Cancer with ultra-fast PSMA-PET scans enhanced by AI. January 15, 2025

eHealth, digital information and technology use of men with prostate cancer. January 14, 2025

Current Status of Neoadjuvant Treatment Before Surgery in High-Risk Localized Prostate Cancer. January 14, 2025

Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical Trial. January 14, 2025

Clinical, Diagnostic and Therapeutic Framework of mHSPC and nmCRPC: A Multidisciplinary Consensus Project of the Italian Society for Uro-Oncology (SIUrO). January 14, 2025

Cardiovascular Risk in Prostate Cancer: JACC: CardioOncology State-of-the-Art Review. January 14, 2025

Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy. January 14, 2025

Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC January 13, 2025

Evaluating the prognostic value of radiomics and clinical features in metastatic prostate cancer using [68Ga]Ga-PSMA-11 PET/CT. January 13, 2025

Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline. January 13, 2025

NXP800 activates the unfolded protein response, altering AR and E2F function to impact castration-resistant prostate cancer growth. January 13, 2025

Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study. January 13, 2025

Contemporary prostate cancer radiation therapy trials may underestimate the risk of biochemical recurrence. January 13, 2025

Novel hormonal agents in men with metastatic castration resistant prostate cancer and reduced performance status: Experiences of a specialized single center. January 10, 2025

Physician Payment Incentives and Active Surveillance in Low-Risk Prostate Cancer. January 10, 2025

Ascertaining provider-level implicit bias in electronic health records with rules-based natural language processing: A pilot study in the case of prostate cancer. January 10, 2025

Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer. January 10, 2025

Time to Castration Resistance is Associated With Overall Survival Even After the Achievement of Castration Resistance in Metastatic Prostate Cancer. January 10, 2025

Page 2 of 1452